FY2024 EPS Estimates for Ayr Wellness Decreased by Analyst

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Investment analysts at Roth Capital dropped their FY2024 earnings per share estimates for Ayr Wellness in a research report issued to clients and investors on Wednesday, November 13th. Roth Capital analyst W. Kirk now forecasts that the company will earn ($1.40) per share for the year, down from their prior forecast of ($1.22). Roth Capital has a “Strong-Buy” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Roth Capital also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.34) EPS, Q1 2025 earnings at ($0.32) EPS, Q2 2025 earnings at ($0.31) EPS, Q3 2025 earnings at ($0.30) EPS, Q4 2025 earnings at ($0.30) EPS and FY2025 earnings at ($1.23) EPS.

AYRWF has been the topic of a number of other reports. Atb Cap Markets cut shares of Ayr Wellness from a “hold” rating to a “strong sell” rating in a report on Wednesday, November 13th. Roth Mkm cut their price target on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a report on Thursday.

Ayr Wellness Stock Performance

OTCMKTS:AYRWF opened at $0.77 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.67 and a current ratio of 1.59. The stock’s fifty day moving average is $1.82 and its 200 day moving average is $1.98. The firm has a market capitalization of $87.90 million, a PE ratio of -0.35 and a beta of 2.00. Ayr Wellness has a fifty-two week low of $0.71 and a fifty-two week high of $4.09.

About Ayr Wellness

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.